Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Pfizer
Jonsson Comprehensive Cancer Center
University of Nebraska
Elephas
Maastricht University Medical Center
Novartis
Elephas
OncoNano Medicine, Inc.
Alpha Tau Medical LTD.
Memorial Sloan Kettering Cancer Center
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Cancer Research UK
Massive Bio, Inc.
British Columbia Cancer Agency
Washington University School of Medicine
Medicenna Therapeutics, Inc.
DEKA Biosciences
Columbia University
Tempus AI
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Maastricht University Medical Center
Cedars-Sinai Medical Center
Algemeen Ziekenhuis Maria Middelares
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Checkpoint Therapeutics, Inc.
VitaMed Research LLC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
European Organisation for Research and Treatment of Cancer - EORTC
UNICANCER
University Hospital Waterford
Maastricht University Medical Center
Klus Pharma Inc.
University Hospital, Ghent
Revolution Medicines, Inc.
Dynavax Technologies Corporation
University of California, San Francisco
Alpha Tau Medical LTD.
SpeciCare
Celgene
Dartmouth-Hitchcock Medical Center
Stanford University
CureOne
sigma-tau i.f.r. S.p.A.